However, on June 13, 2013, the Supreme Court of the United States ruled in the Association for Molecular Pathology v. Myriad Genetics, Inc, that human genes cannot be patented because DNA is a “product of nature.” All gene patents were invalidated with this ruling. However, the ruling did not prohibit the patenting of DNA that is manipulated (i.e., no longer a product of nature) or processes for identifying DNA sequences.